Nephrology and renal transplantation

Jose Maria Cruzado Garrit / Oriol Bestard Matamoros

PRINCIPAL INVESTIGATORS
  • Miquel Hueso Val
  • Joan Torras Ambros
  • Xavier Fulladosa Oliveras
  • Ines Rama Arias
  • Nuria Montero Perez
  • Edoardo Melilli
  • Nuria Lloberas Blanch
  • Ana Maria Sola Martinez
  • Juliana Bordignon Draibe
CLINICAL RESEARCHERS
  • Sergi Codina Sánchez
  • Anna Manonelles Montero
  • Maria Antonia Emilia Meneghini Freyrie
  • Diego Armando Sandoval Rodriguez
  • Àlex Favà Buch
  • Maria Quero Ramos
  • Ana Coloma López
POSTDOCTORAL RESEARCHERS (R2)
  • Elena Crespo Gimeno
PREDOCTORAL RESEARCHERS (R1)
  • Pere Fontova Pale
  • Marta Jarque Sunyer
  • Alba Torija Recasens
  • Adrian Mallen Bareas
  • Laura Martínez Valenzuela
  • Maria Tormo Fabios
SCIENTIFIC SUPPORT
  • Gema Cerezo Contreras
  • Yurema Martinez Vilar
  • Cristian Varela Perea
  • Pilar Arana Sawczuk
  • Nuria Bolaños Peruga
  • Marta Cañete Outeiral
  • Iris Alvarez Teubel
MANAGEMENT SUPPORT
  • Rosa Perez Garzon
  • Carlos Ortega Diaz
  • Carolina Polo Torcal
Translational Medicine
Infectious disease and transplantation

Scientific production

40

PAPERS

Impact factor: 435,576

15 PUBLICATIONS IN FIRST DECILE

31 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Fava, Alexandre; Cucchiari, David; Montero, Nuria; Toapanta, Nestor; Centellas, Francisco J.; Vila-Santandreu, Anna; Coloma, Ana; Meneghini, Maria; Manonelles, Anna; Sellares, Joana; Torres, Irina; Gelpi, Rosana; Lorenzo, Inmaculada; Ventura-Aguiar, Pedro; Cofan, Frederic; Torregrosa, Jose V.; Perello, Manel; Facundo, Carme; Seron, Daniel; Oppenheimer, Federico; Bestard, Oriol; Cruzado, Josep M.; Moreso, Francesc; Melilli, Edoardo. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. AMERICAN JOURNAL OF TRANSPLANTATION. 10.1111/ajt.16246
  • Jarque M, Crespo E, Melilli E, Gutiérrez A, Moreso F, Guirado L, Revuelta I, Montero N, Torras J, Riera L, Meneghini M, Taco O, Manonelles A, Paul J, Seron D, Facundo C, Cruzado JM, Gil Vernet S, Grinyó JM, Bestard O . Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial. CLINICAL INFECTIOUS DISEASES. 10.1093/cid/ciz1209
  • Pascual, J.; Melilli, E.; Jiménez-Martín, C.; González-Monte, E.; Zárraga, S.; Gutiérrez-Dalmau, A.; López-Jiménez, V.; Juega, J.; Muñoz-Cepeda, M.; Lorenzo, I.; Facundo, C.; Ruiz-Fuentes, M.D.C.; Mazuecos, A.; Sánchez-Álvarez, E.; Crespo, M.; Spanish Society of Nephrology COVID-19 Group. COVID-19-related mortality during the first 60 days after kidney transplantation. EUROPAN UROLOGY. 10.1016/j.eururo.2020.06.036
  • Hueso, Miguel; Mallen, Adrian; Casas, Angela; Guiteras, Jordi; Sbraga, Fabrizio; Blasco-Lucas, Arnau; Lloberas, Nuria; Torras, Joan; Cruzado, Josep M.; Navarro, Estanislao. Integrated miRNA/mRNA Counter-Expression Analysis Highlights Oxidative Stress-Related Genes CCR7 and FOXO1 as Blood Markers of Coronary Arterial Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 10.3390/ijms21061943
  • Navarro, Estanislao; Mallen, Adrian; Cruzado, Josep M.; Torras, Joan; Hueso, Miguel. Unveiling ncRNA regulatory axes in atherosclerosis progression. CLINICAL AND TRANSLATIONAL MEDICINE. 10.1186/s40169-020-0256-3

Research highlights

PROJECTS

18 Ongoing projects
3 Granted projects 

 

35 Ongoing clinical trials
9 Started clinical trials

PUBLISHED WORKS

2 Defended theses

INNOVATION

2 Patents

2 licenses

Selected projects

  • Red de Investigación Renal REDINREN (2017 – 2021) PI: CRUZADO GARRIT, JOSE MARIA. Funder: FIS-Instituto de Salud Carlos III.
  • Immunoregulatory effect of dual and opposite costimulatory targeting in renal models of allo and autoimmunity (2018 – 2020) PI: TORRAS AMBROS, JOAN. Funder: FIS-Instituto de Salud Carlos III.
  • Bloqueo del SRAA en pacientes trasplantados renales con presencia de PECs en orina: ensayo clínico aleatorizado de valsartan versus placebo (2019 – 2021) PI: CRUZADO GARRIT, JOSE MARIA. Funder: FIS-Instituto de Salud Carlos III.
  • Estudio de fase IIB, multicéntrico, aleatorizado, doble ciego y controlado con placebo de Verinurad y Alopurinol en pacientes con nefropatía crónica e hyperuricemia (2019 – 2020) PI: HUESO VAL, MIQUEL. Funder ref.: D5495C00002.
  • Ensayo clínico de prueba de concepto, aleatorizado, con tratamiento abierto, dosis ciega en grupos paralelos y tres brazos para investigar la eficacia y seguridad de LNP023 comparado con rituximab en el tratamiento de sujetos con nefropatía membranosa idiopática (2019 – 2020) PI: TORRAS AMBROS, JOAN. Funder ref.: CLNP023D12201.